198 related articles for article (PubMed ID: 29510698)
1. Evolution of H9N2 avian influenza virus in embryonated chicken eggs with or without homologous vaccine antibodies.
Jin H; Wang W; Yang X; Su H; Fan J; Zhu R; Wang S; Shi H; Liu X
BMC Vet Res; 2018 Mar; 14(1):71. PubMed ID: 29510698
[TBL] [Abstract][Full Text] [Related]
2. Antigenic evolution of H9N2 chicken influenza viruses isolated in China during 2009-2013 and selection of a candidate vaccine strain with broad cross-reactivity.
Wei Y; Xu G; Zhang G; Wen C; Anwar F; Wang S; Lemmon G; Wang J; Carter R; Wang M; Sun H; Sun Y; Zhao J; Wu G; Webster RG; Liu J; Pu J
Vet Microbiol; 2016; 182():1-7. PubMed ID: 26711021
[TBL] [Abstract][Full Text] [Related]
3. Genotypic evolution and antigenicity of H9N2 influenza viruses in Shanghai, China.
Ge F; Li X; Ju H; Yang D; Liu J; Qi X; Wang J; Yang X; Qiu Y; Liu P; Zhou J
Arch Virol; 2016 Jun; 161(6):1437-45. PubMed ID: 26935915
[TBL] [Abstract][Full Text] [Related]
4. Generation and protective efficacy of a cold-adapted attenuated avian H9N2 influenza vaccine.
Wei Y; Qi L; Gao H; Sun H; Pu J; Sun Y; Liu J
Sci Rep; 2016 Jul; 6():30382. PubMed ID: 27457755
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cross-lineage protection induced by recombinant H9N2 avian influenza virus inactivated vaccine.
Wang Z; Li Z; Su X; Qiao Y; Fan W; Li H; Shi B; Qin T; Chen S; Peng D; Liu X
Vaccine; 2019 Mar; 37(13):1736-1742. PubMed ID: 30797637
[TBL] [Abstract][Full Text] [Related]
6. Effect of the selection pressure of vaccine antibodies on evolution of H9N2 avian influenza virus in chickens.
Su H; Zhao Y; Zheng L; Wang S; Shi H; Liu X
AMB Express; 2020 May; 10(1):98. PubMed ID: 32462233
[TBL] [Abstract][Full Text] [Related]
7. Generation and evaluation of reassortant influenza vaccines made by reverse genetics for H9N2 avian influenza in Korea.
Song JM; Lee YJ; Jeong OM; Kang HM; Kim HR; Kwon JH; Kim JH; Seong BL; Kim YJ
Vet Microbiol; 2008 Aug; 130(3-4):268-76. PubMed ID: 18374520
[TBL] [Abstract][Full Text] [Related]
8. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
[TBL] [Abstract][Full Text] [Related]
9. Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses.
Kandeil A; Moatasim Y; Gomaa MR; Shehata MM; El-Shesheny R; Barakat A; Webby RJ; Ali MA; Kayali G
Vaccine; 2016 Jan; 34(2):218-224. PubMed ID: 26620838
[TBL] [Abstract][Full Text] [Related]
10. [Mutations of the hemagglutinin gene of H9N2 subtype avian influenza viruses under selective pressure of antibody].
Lou B; Zhu X; Sun B; Cui Z
Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):955-9. PubMed ID: 19873762
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the protective efficacy of a commercial vaccine against different antigenic groups of H9N2 influenza viruses in chickens.
Sun Y; Pu J; Fan L; Sun H; Wang J; Zhang Y; Liu L; Liu J
Vet Microbiol; 2012 Apr; 156(1-2):193-9. PubMed ID: 22019289
[TBL] [Abstract][Full Text] [Related]
12. Generation of highly productive and mammalian nonpathogenic recombinant H9N2 avian influenza viruses by optimization of 3'end promoter and NS genome.
An SH; Lee CY; Choi JG; Lee YJ; Kim JH; Kwon HJ
Vet Microbiol; 2019 Jan; 228():213-218. PubMed ID: 30593370
[TBL] [Abstract][Full Text] [Related]
13. Low pathogenic avian influenza (H9N2) in chicken: Evaluation of an ancestral H9-MVA vaccine.
Ducatez MF; Becker J; Freudenstein A; Delverdier M; Delpont M; Sutter G; Guérin JL; Volz A
Vet Microbiol; 2016 Jun; 189():59-67. PubMed ID: 27259828
[TBL] [Abstract][Full Text] [Related]
14. Genetic and antigenic evolution of H9N2 subtype avian influenza virus in domestic chickens in southwestern China, 2013-2016.
Xia J; Cui JQ; He X; Liu YY; Yao KC; Cao SJ; Han XF; Huang Y
PLoS One; 2017; 12(2):e0171564. PubMed ID: 28158271
[TBL] [Abstract][Full Text] [Related]
15. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
[TBL] [Abstract][Full Text] [Related]
16. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.
Song H; Nieto GR; Perez DR
J Virol; 2007 Sep; 81(17):9238-48. PubMed ID: 17596317
[TBL] [Abstract][Full Text] [Related]
17. Immune Escape Variants of H9N2 Influenza Viruses Containing Deletions at the Hemagglutinin Receptor Binding Site Retain Fitness
Peacock TP; Benton DJ; James J; Sadeyen JR; Chang P; Sealy JE; Bryant JE; Martin SR; Shelton H; Barclay WS; Iqbal M
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468875
[TBL] [Abstract][Full Text] [Related]
18. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
19. Single gene reassortment of highly pathogenic avian influenza A H5N1 in the low pathogenic H9N2 backbone and its impact on pathogenicity and infectivity of novel reassortant viruses.
Moatasim Y; Kandeil A; Mostafa A; Elghaffar SKA; El Shesheny R; Elwahy AHM; Ali MA
Arch Virol; 2017 Oct; 162(10):2959-2969. PubMed ID: 28620809
[TBL] [Abstract][Full Text] [Related]
20. Immune responses of chickens inoculated with a recombinant fowlpox vaccine coexpressing HA of H9N2 avain influenza virus and chicken IL-18.
Chen HY; Shang YH; Yao HX; Cui BA; Zhang HY; Wang ZX; Wang YD; Chao AJ; Duan TY
Antiviral Res; 2011 Jul; 91(1):50-6. PubMed ID: 21549153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
